Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of M...

Addressing Current Questions and Controversies in the Management of Multiple MyelomaПодробнее

Addressing Current Questions and Controversies in the Management of Multiple Myeloma

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia SeriesПодробнее

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Da...Подробнее

Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Da...

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple MyelomaПодробнее

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Sequencing BCMA Myeloma TherapiesПодробнее

Sequencing BCMA Myeloma Therapies

Multiple Myeloma - 2023 Best of Hematology ConferenceПодробнее

Multiple Myeloma - 2023 Best of Hematology Conference

IMWG Conference Series: Reporting from ASH 2022Подробнее

IMWG Conference Series: Reporting from ASH 2022

Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of ActionПодробнее

Reaching the Next Level of Myeloma Patient Care: Antibody Therapy and Novel Mechanisms of Action

Relapsed Refractory Multiple Myeloma | Current Treatment Options | Options on the HorizonПодробнее

Relapsed Refractory Multiple Myeloma | Current Treatment Options | Options on the Horizon

M-protein diagnostics of Multiple Myeloma patients treated with biologicsПодробнее

M-protein diagnostics of Multiple Myeloma patients treated with biologics

Bench to Bedside Immune Therapies in Multiple Myeloma | Ken AndersonПодробнее

Bench to Bedside Immune Therapies in Multiple Myeloma | Ken Anderson

The Future of Antibody Therapies and Drug Conjugates in Multiple MyelomaПодробнее

The Future of Antibody Therapies and Drug Conjugates in Multiple Myeloma

Популярное